Vaccine reduces shingles rate among elderly

Share this article:

Many seniors may soon be scratching and suffering less, thanks to a new shingles vaccine.

The Oka/Merck VZV vaccine decreases the occurrence rate and severity of shingles among older adults, and the pain that accompanies it, according to a report from the Shingles Prevention Study Group. Shingles occurs when a latent chickenpox virus is reactivated. It primarily affects older people, with about half developing complications according to last Thursday's New England Journal of Medicine.

Dr. Michael N. Oxman, at the VA San Diego Healthcare System, and colleagues tested the vaccine in 38,546 adults aged 60 and older. They took the vaccine or a placebo between 1998 and 2001 and were followed until April 2004.

After an average of three years, 315 cases occurred in the vaccine group and 642 in the placebo group. The vaccine also improved the severity of the illness, with an average duration of pain and discomfort of 21 days versus 24 days.

Share this article:

More in News

NY nursing home agrees to $2.2 million settlement in case of false documentation

NY nursing home agrees to $2.2 million settlement ...

Nursing home operator Ralex Services Inc. has agreed to a $2.2 million settlement in a whistleblower case involving forged documents at a facility in New Rochelle, New York.

Common soaps could endanger healthcare workers, study finds

Healthcare facilities should consider replacing antibacterial soaps containing the chemical triclosan, University of California-San Francisco researchers assert in a recent Journal of Occupational and Environmental Medicine article. The conclusion echoes recently updated hand hygiene guidelines.

Mandatory staff hours, better high-acuity care could improve quality of life in ...

A nursing home's staffing patterns and admissions trends are among the most important factors driving residents' quality of life over time, according to recently published research findings.